Management of parapneumonic effusions

Journal of Clinical and Analytical Medicine

Volumn 1, Issue 2, 2010, Pages 48-51

  Light, Richard W ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DEOXYRIBONUCLEASE; FIBRINOLYTIC AGENT; GLUCOSE; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PLACEBO; PROCALCITONIN; SODIUM CHLORIDE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

BACTERIAL PNEUMONIA; BACTERIUM CULTURE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; EMPYEMA; ENTEROBACTERIACEAE; ENTEROCOCCUS; GLUCOSE BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PARAPNEUMONIC EFFUSION; PH; PLEURA EFFUSION; PLEURA FLUID; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE; THORACOCENTESIS; THORACOTOMY; THORAX DRAINAGE; THORAX RADIOGRAPHY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 79952221867     PISSN: 13090720     EISSN: 13092014     Source Type: Journal    
DOI: 10.4328/JCAM.10.2.41     Document Type: Review

References (16)

1. Light RW: Pleural Diseases. Fifth Edition. Lippincott, Williams and Wilkins, Baltimore, 2007.
2. Hasley PB, Albaum MN, Li Y-H, Fuhrman CR, Britton CA, Marrie TJ et al: Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med 1996; 156: 2206-2212.
3. Foster S, Maskell N: Bacteriology of complicated parapneumonic effusions. Current Opin Pul Med 2007; 13: 319-323
4. Light RW, Girard WM, Jenkinson SG, George RB: Parapneumonic effusions. Am J Med 1980; 69: 507-511.
5. Porcel JM, Vlves M, Cao G, Bielsa S, Ruiz-Gonzalez A, Martinez-Iribarren A, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009; 34: 1383-1389.
6. Colice GL, Curtis A, Deslauriers J, Heffner J, Light RW, Littenberg B, Sahn S, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions: An evidence-based guideline. Chest 2000; 118: 1158-1171
7. Cheng D-S, Rodriguez RM, Rogers J, Wagster M, Starnes DL, Light RW: Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998; 114: 1368-1372.
8. Maskell NA, Davies CW, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352: 865-74.
9. Rahman NM, Maskell N, Davies CW, West A, Teoh R, Arnold T, et al. Primary result of the 2nd multi-centre intrapleural sepsis (MIST2) trial; randomized trial of intrapleural tPA and DNAse in pleural infection. Thorax 2009; 64 (Suppl IV); pp A1.
10. Zhu Z, Hawthorne ML, Guo Y, et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006; 129: 1577-83.
11. Landreneau RJ, Keenan RJ, Hazelrigg SR, et al. Thoracoscopy for empyema and hemothorax. Chest 1995; 109: 18-24.
12. Cassina PC, Hauser M, Hillejan L, et al. Video-assisted thoracoscopy in the treatment of pleural empyema: stage-based management and outcome. J Thorac Cardiovasc Surg 1999; 117: 234-8.
13. Lawrence DR, Ohri SK, Moxon RE, et al. Thoracoscopic debridement of empyema thoracis. Ann Thorac Surg 1997; 64: 1448-50.
14. Striffeler H, Gugger M, Im Hof V, et al. Video-assisted thoracoscopic surgery for fibrinopurulent pleural empyema in 67 patients. Ann Thorac Surg 1998; 65: 319-23.
15. Neff CC, van Sonnenberg E, Lawson DW, et al. CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage. Radiology 1990; 176: 195-7.
16. Jimenez Castro D, Diaz G, Perez-Rodriguez E, et al Prognostic features of residual pleural thickening in parapneumonic pleural effusions. Europ Respir J 2003; 21: 952-5.